Compound ID | 245
Synonym(s): TP-434 | Xerava
Class: Tetracycline
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Broad spectrum activity including multidrug-resistant strains |
| Description: | A tetracycline derivative (fluorocycline) |
| Institute where first reported: | Tetraphase Pharmaceuticals, USA |
| Year first mentioned: | 2010 |
| Highest development stage: | Approved by FDA in 2018 |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/54726192 |
| Guide to Pharmacology: | eravacycline |
| Citations: |
|